Else Announces Results from Annual General Meeting of Shareholders and New Director
30 June 2023 - 8:53AM
ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL)
(the “
Company”) announces that at its annual
general meeting of shareholders held on June 29, 2023 all
resolutions put to its shareholders were passed. A total of
30,534,355 or 26.94% of the Company’s issued and outstanding shares
were represented at the meeting.
At the meeting, shareholders approved setting
the number of directors at seven and re-electing all of
management’s director nominees, as listed in the management
information circular dated May 8, 2023, to the board of directors
to serve until the next annual general meeting. The election of
directors was approved by a majority vote of shareholders as
follows:
Motions |
Votes for |
Votes withheld |
Number |
Percent |
Number |
Percent |
Hamutal Yitzhak |
30,458,382 |
99.75% |
75,973 |
0.25% |
Uriel Kesler |
30,457,682 |
99.75% |
76,673 |
0.25% |
Sokhie Puar |
30,452,922 |
99.73% |
81,433 |
0.27% |
Satwinder Mann |
30,511,829 |
99.93% |
22,526 |
0.07% |
Eli Ronen |
30,512,029 |
99.93% |
22,326 |
0.07% |
Akash Bedi |
30,507,369 |
99.91% |
26,986 |
0.09% |
Yaki Lutski |
30,511,329 |
99.92% |
23,026 |
0.08% |
At the meeting, shareholders also approved: (i)
the re-appointment of Kost Forer Gabbay & Kasierer, a member
firm of Ernst & Young Global Limited, as the Company’s auditor;
(ii) the amendment of certain issued and outstanding common share
purchase warrants; (iii) the issuance of common shares to Lind
Global Fund II LP; and (iv) an amendment to the Company’s stock
option plan to increase the number of common shares reserved for
issuance to 15% of the issued and outstanding common shares of the
Company from time to time at the date of the grant of options. For
further details please see the report of voting results available
on the Company’s SEDAR profile.
The Company welcomes Mr. Yaki Lutski to the
board of directors following his election at the annual general
meeting. Mr. Lutski began his career with the Israel Defense
Forces, including serving as Deputy Chief Medical Officer.
Subsequently, Mr. Lutski worked as a consultant for companies in
strategic management, marketing systems control, pharmaceutical,
and energy sectors. From 2001 to 2003, he was CEO of Seku Genes, a
biotechnology company, and Chairman of Dan Recycling. From
2004-2005, he served as CEO of Medisell, a mobile medical services
company. From 2006 to 2014, he was Chairman of Coppola Medical, a
tattoo removal equipment company. From 2009-2004, he served as
Chairman of Elitar Medical Systems Inc. From 2009-2016, he was a
member of Senior Management of Atlantium Technologies Ltd., a water
systems company. Mr. Lutski has been a shareholder and Chairman of
UniKo (formerly F.C.C. Hanjin Shipping), a shipping and logistics
group, since 2007. Mr. Lutski has also served as an external
director for Aviation Links Ltd., Mivtach Shamir Holdings Ltd., and
EL-AL. Mr, Lutski is a graduate of Bar Ilan University with a
Bachelor of Arts Degree from the Department of Economics,
Sociology, and Political Science. Mr. Lutski also received a Master
of Arts Degree from the University of Haifa in Public Health
Systems Management.
About Else Nutrition Holdings
Inc.
Else Nutrition Holdings Inc. is a food and
nutrition company (in the international expansion stage) focused on
developing innovative, clean, and plant-based food and nutrition
products for infants, toddlers, children, and adults. Its
revolutionary, plant-based, non-soy formula is a clean-ingredient
alternative to dairy-based formulas. Since launching its
Plant-Based Complete Nutrition for Toddlers, made of whole foods,
almonds, buckwheat, and tapioca, the brand has received thousands
of powerful testimonials and reviews from parents, gained national
retailer support, and achieved rapid sales growth.
Awards and Recognition:
- “2017 Best Health and Diet Solutions” award at Milan's Global
Food Innovation Summit
- #1 Best Seller on Amazon in the
Fall of 2020 in the New Baby & Toddler Formula Category
- “Best Dairy Alternative” Award 2021
at World Plant-Based Expo
- Nexty Award Finalist at Expo West
2022 in the Plant-Based lifestyle category
- During September 2022, Else Super
Cereal reached the #1 Best Seller in Baby Cereal across all brands
on Amazon
For more information, visit
www.elsenutrition.com or @elsenutrition on Facebook and
Instagram.
For more information,
contact:Mrs. Hamutal Yitzhak, CEO, Co-Founder &
DirectorELSE Nutrition Holdings Inc.E: hamutaly@elsenutrition.com
P: +972(0)3-6445095
Mr. Sokhie Puar, Lead Director of Else
NutritionEmail: sokhiep@elsenutrition.com P: 604-603-7787
Investor Relations Contact:
RBMG – RB Milestone Group LLCTrevor Brucato,
Managing DirectorE: baby@rbmilestone.comwww.rbmilestone.com
Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
This news release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will”, “expects” or similar
expressions. Forward-looking statements in this news release
include statements with respect to the extension of the Performance
Warrants. Such forward-looking statements reflect current
estimates, beliefs and assumptions, which are based on management’s
perception of current conditions and expected future developments,
as well as other factors management believes are appropriate in the
circumstances. No assurance can be given that the foregoing will
prove to be correct. Readers are cautioned not to place undue
reliance on any forward-looking statements, which reflect
management’s expectations only as of the date of this news release.
The Company disclaims any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.
Else Nutrition (TSX:BABY)
Historical Stock Chart
From Apr 2024 to May 2024
Else Nutrition (TSX:BABY)
Historical Stock Chart
From May 2023 to May 2024